Assembly Biosciences, Inc. (ASMB) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $20.06 (-3.84%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 20, 2025 | Salim Syed | Mizuho Securities | $40.00 | +99.4% |
| Sep 24, 2025 | Roy Buchanan | JMP Securities | $38.00 | +89.4% |
| Sep 24, 2024 | Salim Syed | Mizuho Securities | $36.00 | +79.5% |
| Sep 20, 2024 | Dennis Ding | Jefferies | $35.00 | +74.5% |
Top Analysts Covering ASMB
ASMB vs Sector & Market
| Metric | ASMB | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.41 |
| Analyst Count | 5 | 8 | 19 |
| Target Upside | +157.6% | +153002.0% | +21.5% |
| P/E Ratio | -49.44 | 3.52 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $47M | $47M | $47M | 1 |
| 2027-03-31 | $19M | $19M | $19M | 1 |
| 2027-06-30 | $48M | $48M | $48M | 1 |
| 2027-09-30 | $48M | $48M | $48M | 1 |
| 2027-12-31 | $57M | $57M | $57M | 1 |
| 2028-12-31 | $66M | $66M | $66M | 3 |
| 2029-12-31 | $28M | $28M | $28M | 2 |
| 2030-12-31 | $124M | $124M | $124M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.18 | $0.18 | $0.18 | 1 |
| 2027-03-31 | $-0.73 | $-0.73 | $-0.73 | 1 |
| 2027-06-30 | $-1.21 | $-1.21 | $-1.21 | 1 |
| 2027-09-30 | $-1.19 | $-1.19 | $-1.19 | 1 |
| 2027-12-31 | $0.20 | $0.20 | $0.20 | 1 |
| 2028-12-31 | $-4.54 | $-1.93 | $0.67 | 2 |
| 2029-12-31 | $-3.30 | $-3.30 | $-3.30 | 1 |
| 2030-12-31 | $-1.81 | $-1.81 | $-1.81 | 1 |
Frequently Asked Questions
What is the analyst consensus for ASMB?
The consensus among 5 analysts covering Assembly Biosciences, Inc. (ASMB) is Buy with an average price target of $51.67.
What is the highest price target for ASMB?
The highest price target for ASMB is $40.00, set by Salim Syed at Mizuho Securities on 2025-11-20.
What is the lowest price target for ASMB?
The lowest price target for ASMB is $35.00, set by Dennis Ding at Jefferies on 2024-09-20.
How many analysts cover ASMB?
5 analysts have issued ratings for Assembly Biosciences, Inc. in the past 12 months.
Is ASMB a buy or sell right now?
Based on 5 analyst ratings, ASMB has a consensus rating of Buy (2.00/5) with a +157.6% upside to the consensus target of $51.67.
What are the earnings estimates for ASMB?
Analysts estimate ASMB will report EPS of $0.18 for the period ending 2026-12-31, with revenue estimated at $47M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.